104 related articles for article (PubMed ID: 15308017)
1. [Effect of the tetra-arsenic tetra-sulfide (As4S4) on the corrected QT interval in the treatment of acute promyelocytic leukemia].
Shen JC; Liu KY; Jiang B; Lu XJ; Lu DP
Zhonghua Xue Ye Xue Za Zhi; 2004 Jun; 25(6):359-61. PubMed ID: 15308017
[TBL] [Abstract][Full Text] [Related]
2. The effect of arsenic trioxide on QT interval prolongation during APL therapy.
Zhou J; Meng R; Li X; Lu C; Fan S; Yang B
Chin Med J (Engl); 2003 Nov; 116(11):1764-6. PubMed ID: 14642155
[TBL] [Abstract][Full Text] [Related]
3. [Mechanism of tetra-arsenic tetra-sulfide in inducing apoptosis of acute promyelocytic leukemia cells].
Teng ZP; Zhang P; Zhu HH; Hao HY; Qin XY; Hao L; Xu H; Lu DP
Beijing Da Xue Xue Bao Yi Xue Ban; 2006 Jun; 38(3):236-8. PubMed ID: 16778962
[TBL] [Abstract][Full Text] [Related]
4. Oral tetra-arsenic tetra-sulfide formula versus intravenous arsenic trioxide as first-line treatment of acute promyelocytic leukemia: a multicenter randomized controlled trial.
Zhu HH; Wu DP; Jin J; Li JY; Ma J; Wang JX; Jiang H; Chen SJ; Huang XJ
J Clin Oncol; 2013 Nov; 31(33):4215-21. PubMed ID: 24127444
[TBL] [Abstract][Full Text] [Related]
5. Effect of arsenic trioxide on QT interval in patients with advanced malignancies.
Barbey JT; Pezzullo JC; Soignet SL
J Clin Oncol; 2003 Oct; 21(19):3609-15. PubMed ID: 14512391
[TBL] [Abstract][Full Text] [Related]
6. Tetra-arsenic tetra-sulfide (As4S 4) promotes apoptosis in retinoid acid -resistant human acute promyelocytic leukemic NB4-R1 cells through downregulation of SET protein.
Liu Y; He P; Liu F; Zhou N; Cheng X; Shi L; Zhu H; Zhao J; Wang Y; Zhang M
Tumour Biol; 2014 Apr; 35(4):3421-30. PubMed ID: 24430359
[TBL] [Abstract][Full Text] [Related]
7. Population Pharmacokinetics and Safety of Oral Tetra-Arsenic Tetra-Sulfide Formula in Pediatric Acute Promyelocytic Leukemia.
Zhang L; Yang XM; Chen J; Hu L; Yang F; Zhou Y; Zhao BB; Zhao W; Zhu XF
Drug Des Devel Ther; 2021; 15():1633-1640. PubMed ID: 33911851
[TBL] [Abstract][Full Text] [Related]
8. Tetra-arsenic tetra-sulfide enhances NK-92MI mediated cellular immunotherapy in all-trans retinoic acid-resistant acute promyelocytic leukemia.
Liu Y; Jia Y; Liu Y; Chen X; Zhang M
Invest New Drugs; 2022 Dec; 40(6):1231-1243. PubMed ID: 36287298
[TBL] [Abstract][Full Text] [Related]
9. Arsenic sulfide promotes apoptosis in retinoid acid resistant human acute promyelocytic leukemic NB4-R1 cells through downregulation of SET protein.
Tian Y; Liu Y; He P; Liu F; Zhou N; Cheng X; Shi L; Zhu H; Zhao J; Wang Y; Zhang M
PLoS One; 2014; 9(1):e83184. PubMed ID: 24454695
[TBL] [Abstract][Full Text] [Related]
10. Prohibitin promotes apoptosis of promyelocytic leukemia induced by arsenic sulfide.
He P; Liu Y; Qi J; Zhu H; Wang Y; Zhao J; Cheng X; Wang C; Zhang M
Int J Oncol; 2015 Dec; 47(6):2286-95. PubMed ID: 26498315
[TBL] [Abstract][Full Text] [Related]
11. [Application of all-trans retinoic acid combining chemotherapy and As4S4 in the maintenance treatment of patients with acute promyelocytic leukemia].
Lin QD; Wei XD; Wang P; Liu YY; Zhang LN; Li YF; Gao QL; Zhu XH; Zhang YL; Fang BJ; Yue H; Du JW; Jiang DX; Hu JY; Song YP
Zhonghua Xue Ye Xue Za Zhi; 2007 Jan; 28(1):19-21. PubMed ID: 17649720
[TBL] [Abstract][Full Text] [Related]
12. Tetra-arsenic tetra-sulfide for the treatment of acute promyelocytic leukemia: a pilot report.
Lu DP; Qiu JY; Jiang B; Wang Q; Liu KY; Liu YR; Chen SS
Blood; 2002 May; 99(9):3136-43. PubMed ID: 11964275
[TBL] [Abstract][Full Text] [Related]
13. Arrhythmogenic effects of arsenic trioxide in patients with acute promyelocytic leukemia and an electrophysiological study in isolated guinea pig papillary muscles.
Yamazaki K; Terada H; Satoh H; Naito K; Takeshita A; Uehara A; Katoh H; Ohnishi K; Hayashi H
Circ J; 2006 Nov; 70(11):1407-14. PubMed ID: 17062962
[TBL] [Abstract][Full Text] [Related]
14. [Chronic hepatic damage in acute promyelocytic leukemia patients treated with tetra-arsenic tetra-sulfide].
Qin XY; Jiang B; Li GX; Lu DP
Zhonghua Xue Ye Xue Za Zhi; 2006 Apr; 27(4):259-63. PubMed ID: 16875560
[TBL] [Abstract][Full Text] [Related]
15. Tetraarsenictetrasulfide and Arsenic Trioxide Exert Synergistic Effects on Induction of Apoptosis and Differentiation in Acute Promyelocytic Leukemia Cells.
Wang S; Zhou M; Ouyang J; Geng Z; Wang Z
PLoS One; 2015; 10(6):e0130343. PubMed ID: 26110921
[TBL] [Abstract][Full Text] [Related]
16. [A clinical pharmacokinetic study of multi-dose oral tetra-arsenic tetra-sulfide combination therapy in acute promyelocytic leukemia].
Wang FR; Lou YQ; Lu DP
Zhonghua Nei Ke Za Zhi; 2005 Oct; 44(10):730-3. PubMed ID: 16255875
[TBL] [Abstract][Full Text] [Related]
17. Ventricular repolarization dynamics in arsenic trioxide treatment of acute promyelocytic leukemia.
Sun Y; Wang L; Que Y; Zhu H; Yang X; Li D
Int J Cardiol; 2020 May; 306():163-167. PubMed ID: 31761398
[TBL] [Abstract][Full Text] [Related]
18. Effects of tetra-arsenic tetra-sulfide on BXSB lupus-prone mice: a pilot study.
Zhao Y; Wen G; Qiao Z; Xu H; Sun Q; Huang H; Shan S; Mu Z; Zhang J
Lupus; 2013 Apr; 22(5):469-76. PubMed ID: 23554035
[TBL] [Abstract][Full Text] [Related]
19. Prevalence, management, and clinical consequences of QT interval prolongation during treatment with arsenic trioxide.
Roboz GJ; Ritchie EK; Carlin RF; Samuel M; Gale L; Provenzano-Gober JL; Curcio TJ; Feldman EJ; Kligfield PD
J Clin Oncol; 2014 Nov; 32(33):3723-8. PubMed ID: 25245447
[TBL] [Abstract][Full Text] [Related]
20. As
Wu D; Dong W; Fang K; Wang M
Technol Cancer Res Treat; 2019; 18():1533033819896806. PubMed ID: 31868118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
